Strengthening Cardiovascular Pharmacogenomics Implementation through Twinning
- Project No.: 2026-EPTWIN-17732
- Project acronym: CardioPgX-TWIN
- Principal investigator (LSMU): prof. Vaiva Lesauskaitė
- Project duration: from 2026-06 to 2027-06
- Funding programme: EPPermed: Twinning Call (EPTWIN)
- Total project value: 50 000 Eur
- Part of the project value allocated to the LSMU: 27 937,25 Eur
- Project coordinator: LSMU
- Project partner: University of Extremadura
Summury
The CardioPgX-TWIN project aims to establish a practical model for the implementation of pharmacogenomics (PGx) in cardiology at LSMU Kaunas Hospital. The model will include clear SOPs, a governance structure, a multidisciplinary case discussion format, and a PGx recommendation report, enabling genetic information to be used in a structured way to support individualized medication prescribing.
Result
A functional, standardized, and scalable model for the implementation of pharmacogenomics in cardiology will be established at LSMU Kaunas Hospital, enabling genetic information to be used to support individualized medication prescribing.
